- The trend backdrop is active with a 12-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
IBT-B
STO
Week ended 07 Aug 2026
Weekly Investor Report
Infant Bacterial Therapeutics AB (publ) · Healthcare · Biotechnology
Latest close
66.00 SEK
-1.5%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 17.6% above the Trend Line and sits at 55.4% of its 52-week range. The latest completed week returned -1.5%, after a 1.5% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
50
out of 100
Latest Close
66.00 SEK
7 Aug 2026
1W Return
-1.5%
latest completed week
4W Return
1.5%
short-term follow-through
12W Return
15.8%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- Next-week expectancy is negative at 44.81% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.5%
Latest completed week; four-week move 1.5%.
Indicator stack
68/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.81%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 17.6% above the Trend Line and sits at 55.4% of its 52-week range. The latest completed week returned -1.5%, after a 1.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9612-week average 0.71
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.96Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.5% over four weeks, 15.8% over 12 weeks, and 31.2% over one year. The current trend has remained active for 12 consecutive weeks.
Performance by holding period
Active trend streak12 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.09Latest activity-pressure read.
Pressure change-19.6%Four-week change in activity pressure.
Leadership2.71Latest relative-leadership reading.
RS change-54.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-21.7%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+12.9%Week of 13 Feb.
Worst week-10.2%Week of 27 Feb.
Latest week-1.5%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains10
Flat weeks0
Modest losses9
Sharp losses2
Recent vol4.5%13-week weekly-return volatility.
Base vol6.9%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew5.3% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank36 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Biotechnology
4-week rank16 / 58
Group average3.5%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD53.4%positive activity pressure
RS22.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape50/100
Trend, activity pressure, participation, and risk combine to a 50/100 tape read.
Indicator analysis86/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 9/12.
Activity pressure 0.96; No reversal markers Next-Week ExpectancyNegative 44.81%Next-week expectancy is negative with a 44.81% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
We're Hopeful That Infant Bacterial Therapeutics (STO:IBT B) Will Use Its Cash Wisely Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 66.00 SEK | -1.5% | 56.13 SEK | 65.71 SEK | 1.09 | 2.71 | 13.0K | On |
| 31 Jul 2026 | 67.00 SEK | 0.3% | 55.60 SEK | 65.81 SEK | 1.16 | 6.43 | 12.3K | On |
| 24 Jul 2026 | 66.80 SEK | 2.6% | 55.03 SEK | 65.95 SEK | 1.22 | 7.76 | 21.2K | On |
| 17 Jul 2026 | 65.10 SEK | 0.2% | 54.44 SEK | 66.05 SEK | 1.25 | 6.98 | 33.1K | On |
| 10 Jul 2026 | 65.00 SEK | -7.1% | 53.87 SEK | 66.21 SEK | 1.35 | 5.96 | 31.5K | On |
| 3 Jul 2026 | 70.00 SEK | 12.2% | 53.37 SEK | 66.26 SEK | 1.34 | 11.86 | 2.7K | On |
| 26 Jun 2026 | 62.40 SEK | -1.0% | 52.48 SEK | 66.21 SEK | 1.34 | 2.88 | 4.1K | On |
| 19 Jun 2026 | 63.00 SEK | 3.3% | 52.02 SEK | 66.13 SEK | 1.27 | 3.01 | 87.6K | On |
| 12 Jun 2026 | 61.00 SEK | 6.3% | 51.70 SEK | 66.03 SEK | 1.11 | 1.66 | 5.9K | On |
| 5 Jun 2026 | 57.40 SEK | 2.9% | 51.34 SEK | 65.93 SEK | 1.15 | -4.74 | 1.5K | On |
| 29 May 2026 | 55.80 SEK | 0.4% | 51.48 SEK | 65.85 SEK | 1.18 | -8.45 | 60.5K | On |
| 22 May 2026 | 55.60 SEK | -2.5% | 51.58 SEK | 65.77 SEK | 1.07 | -9.49 | 66.9K | On |
| 15 May 2026 | 57.00 SEK | 5.0% | 51.74 SEK | 65.69 SEK | 1.02 | -4.40 | 40.0K | Off |
| 8 May 2026 | 54.30 SEK | 0.7% | 51.94 SEK | 65.60 SEK | 0.85 | -10.34 | 149.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.